A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

December 4, 2020

Primary Completion Date

April 9, 2024

Study Completion Date

October 31, 2028

Conditions
IgG4 Related Disease
Interventions
DRUG

Inebilizumab

Inebilizumab is a monoclonal antibody that depletes B cells.

OTHER

Placebo

Placebo

Trial Locations (72)

21287

Viela Bio Investigative Site, Baltimore

30322

Viela Bio Investigative Site, Atlanta

94305

Viela Bio Investigative Site, Palo Alto

02114

Viela Bio Investigative Site, Boston

Unknown

Viela Bio Investigative Site, Buenos Aires

Viela Bio Investigative Site, Mendoza

Viela Bio Investigative Site, Auchenflower

Viela Bio Investigative Site, Adelaide

Viela Bio Investigative Site, Fitzroy

Viela Bio Investigative Site, Sherbrooke

Viela Bio Investigative Site 1, Toronto

Viela Bio Investigative Site 2, Toronto

Viela Bio Investigative Site, Hohhot

Viela Bio Investigative Site 1, Beijing

Viela Bio Investigative Site 2, Beijing

Viela Bio Investigative Site 3, Beijing

Viela Bio Investigative Site 4, Beijing

Viela Bio Investigative Site 5, Beijing

Viela Bio Investigative Site, Guandong

Viela Bio Investigative Site, Shang’ai

Viela Bio Investigative Site, Shenyang

Viela Bio Investigative Site, Wuhan

Viela Bio Investigative Site, Clichy

Viela Bio Investigative Site, Lille

Viela Bio Investigative Site, Marseille

Viela Bio Investigative Site, Nantes

Viela Bio Investigative Site, Pessac

Viela Bio Investigative Site, Berlin

Viela Bio Investigative Site, Lübeck

Viela Bio Investigative Site, München

Viela Bio Investigative Site, Hong Kong

Viela Bio Investigative Site, Debrecen

Viela Bio Investigative Site, Szeged

Viela Bio Investigative Site, Bangalore

Viela Bio Investigative Site, Cork

Viela Bio Investigative Site, Kfar Saba

Viela Bio Investigative Site, Petah Tikva

Viela Bio Investigative Site, Tel Aviv

Viela Bio Investigative Site, Tel Litwinsky

Viela Bio Investigative Site, Florence

Viela Bio Investigative Site, Milan

Viela Bio Investigative Site, Pisa

Viela Bio Investigative Site, Reggio Emilia

Viela Bio Investigative Site, Torino

Viela Bio Investigative Site, Verona

Viela Bio Investigative Site, Fukuoka

Viela Bio Investigative Site, Hokkaido

Viela Bio Investigative Site, Hyōgo

Viela Bio Investigative Site, Ishikawa

Viela Bio Investigative Site, Kyoto

Viela Bio Investigative Site, Niigata

Viela Bio Investigative Site 2, Osaka

Viela Bio Investigative Site, Osaka

Viela Bio Investigative Site, Tokyo

Viela Bio Investigative Site, Toyama

Viela Bio Investigative Siite, Tlalpan

Viela Bio Investigative Site, Amsterdam

Viela Bio Investigative Site, Rotterdam

Viela Bio Investigative Site, Warsaw

Viela Bio Investigative Site, Wroclaw

Viela Bio Investigative Site 2, Barcelona

Viela Bio Investigative Site, Barcelona

Viela Bio Investigative Site, Madrid

Viela Bio Investigative Site, Valencia

Viela Bio Investigative Site, Gothenburg

Viela Bio Investigative Site, Stockholm

Viela Bio Investigative Site, Ankara

Viela Bio Investigative Site, Istanbul

Viela Bio Investigative Site, Leeds

Viela Bio Investigative Site, London

Viela Bio Investigative Site, Newcastle

Viela Bio Investigative Site, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY